SCHEMBL4834762

SCHEMBL4834762

O=C1C2CC3C(=O)N(OS(=O)(=O)c4cc(C(F)(F)F)cc(C(F)(F)F)c4)C(=O)C3CC2C(=O)N1OS(=O)(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.36
CNR1 P21554 6/20 0.34
PARL Q9H300 2/20 0.34
STS P08842 2/20 0.34
KCNH2 Q12809 3/20 0.33
TACR1 P25103 2/20 0.33
CES2 O00748 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4831781 0.88 CES2 (0.36) GAACNR1PARLSTSCES2
SCHEMBL4826369 0.86 CA1 (0.43) CNR1PARLKMT2A
SCHEMBL4834153 0.85 PTGS2 (0.41) PARLMEN1KMT2A
SCHEMBL6424823 0.82 GAA (0.33) GAACNR1PARLSTSCES2
SCHEMBL4826549 0.75 CA1 (0.47) CNR1PARLL3MBTL1KMT2A
SCHEMBL4831931 0.75 KMT2A (0.55) PARLMEN1KMT2A
SCHEMBL4831889 0.74 LIPE (0.44) PARLMEN1KMT2A
SCHEMBL4831892 0.74 KMT2A (0.43) PARLMEN1KMT2A
SCHEMBL6743844 0.73 KDM4E (0.62) GAAPARLL3MBTL1MEN1KMT2A
SCHEMBL4837033 0.73 PARL (0.64) PARLL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 GAA 2435/4885CNR1 2157/4885PARL 1086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.